Targeted Chemo-elimination (TCE) of Malaria

NACompletedINTERVENTIONAL
Enrollment

8,000

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Plasmodium Falciparum Malaria
Interventions
DRUG

malaria elimination using DP and low-dose primaquine

Treatment of all persons resident in the intervention villages including those who do not have malaria parasites as detected by rapid diagnostic test. This is to interrupt p.f malaria transmission by removing the reservoir of all potentially infectious people from the area.

Trial Locations (5)

372

Pailin, Pailin

Unknown

Mahidol Oxford Clincal Research Unit, Myanmar, Rangoon

Savannakhet, Savannakhet

Shoklo Malaria Research Unit, Mae Sot

Ward 1, District 5

Oxford University Clinical Research Unit - Vietnam, Ho Chi Minh City

Sponsors
All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

collaborator

National Centre for Parasitology, Entomology and Malaria Control, Cambodia

OTHER

collaborator

FHI 360

OTHER

collaborator

Oxford University Clinical Research Unit, Vietnam

OTHER

collaborator

National Malaria Control Program, Vietnam

OTHER_GOV

collaborator

Myanmar Oxford Clinical Research Unit

OTHER

collaborator

National Malaria Control Program, Myanmar

OTHER_GOV

collaborator

Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

OTHER

collaborator

Shoklo Malaria Research Unit

OTHER

lead

University of Oxford

OTHER

NCT01872702 - Targeted Chemo-elimination (TCE) of Malaria | Biotech Hunter | Biotech Hunter